221 related articles for article (PubMed ID: 21321603)
61. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
[TBL] [Abstract][Full Text] [Related]
62. Deciphering the potential ability of RG108 in cisplatin-induced HEI-OC1 ototoxicity: a research based on RNA-seq and molecular biology experiment.
Zhang D; Sun Y; Lei M; Wang Y; Cai C
Hereditas; 2023 Apr; 160(1):18. PubMed ID: 37088824
[TBL] [Abstract][Full Text] [Related]
63. Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis.
Song GY; Chung CS; Rhee RJ; Cioffi WG; Ayala A
Intensive Care Med; 2005 Nov; 31(11):1564-9. PubMed ID: 16172848
[TBL] [Abstract][Full Text] [Related]
64. Attenuated expression of tenascin-C in ovalbumin-challenged STAT4-/- mice.
Meuronen A; Karisola P; Leino M; Savinko T; Sirola K; Majuri ML; Piirilä P; Virtanen I; Mäkelä M; Laitinen A; Laitinen LA; Alenius H
Respir Res; 2011 Jan; 12(1):2. PubMed ID: 21205293
[TBL] [Abstract][Full Text] [Related]
65. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
66. SERCA2 protects against cisplatin-induced damage of auditory cells: Possible relation with alleviation of ER stress.
Xu Y; Zhao H; Wang F; Xu S; Wang C; Li Y; Wang Y; Nong H; Zhang J; Cao Z; Chen C; Li J
Toxicol Appl Pharmacol; 2024 May; 486():116947. PubMed ID: 38688426
[TBL] [Abstract][Full Text] [Related]
67. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
68. Prednisone inhibits the IL-1β-induced expression of COX-2 in HEI-OC1 murine auditory cells through the inhibition of ERK-1/2, JNK-1 and AP-1 activity.
Hong H; Jang BC
Int J Mol Med; 2014 Dec; 34(6):1640-6. PubMed ID: 25319133
[TBL] [Abstract][Full Text] [Related]
69. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway.
Sun C; Yao Y; Zhang C; Tong D; Xie B
Otol Neurotol; 2019 Aug; 40(7):965-971. PubMed ID: 31135681
[TBL] [Abstract][Full Text] [Related]
70. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms.
Finnegan A; Grusby MJ; Kaplan CD; O'Neill SK; Eibel H; Koreny T; Czipri M; Mikecz K; Zhang J
J Immunol; 2002 Sep; 169(6):3345-52. PubMed ID: 12218156
[TBL] [Abstract][Full Text] [Related]
71. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G
Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530
[TBL] [Abstract][Full Text] [Related]
72. Hydroxytyrosol enhances cisplatin-induced ototoxicity: Possible relation to the alteration in the activity of JNK and AIF pathways.
Zhang W; Man R; Yu X; Yang H; Yang Q; Li J
Eur J Pharmacol; 2020 Nov; 887():173338. PubMed ID: 32781170
[TBL] [Abstract][Full Text] [Related]
73. 3-Aminotriazole protects from CoCl2-induced ototoxicity by inhibiting the generation of reactive oxygen species and proinflammatory cytokines in mice.
Lee JN; Kim SG; Lim JY; Dutta RK; Kim SJ; Choe SK; So HS; Park R
Arch Toxicol; 2016 Apr; 90(4):781-91. PubMed ID: 25820916
[TBL] [Abstract][Full Text] [Related]
74. Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK/FOXO3a pathway.
Liang Z; Zhang T; Zhan T; Cheng G; Zhang W; Jia H; Yang H
J Neurophysiol; 2021 Apr; 125(4):1202-1212. PubMed ID: 33625942
[TBL] [Abstract][Full Text] [Related]
75. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.
Villarino AV; Tato CM; Stumhofer JS; Yao Z; Cui YK; Hennighausen L; O'Shea JJ; Hunter CA
J Exp Med; 2007 Jan; 204(1):65-71. PubMed ID: 17227909
[TBL] [Abstract][Full Text] [Related]
76. Involvement of TNF-α and IFN-γ in Inflammation-Mediated Cochlear Injury.
Moon SK; Woo JI; Lim DJ
Ann Otol Rhinol Laryngol; 2019 Jun; 128(6_suppl):8S-15S. PubMed ID: 31092034
[TBL] [Abstract][Full Text] [Related]
77. Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of cisplatin in mice.
Oh GS; Kim HJ; Choi JH; Shen A; Kim CH; Kim SJ; Shin SR; Hong SH; Kim Y; Park C; Lee SJ; Akira S; Park R; So HS
J Immunol; 2011 Jan; 186(2):1140-50. PubMed ID: 21148032
[TBL] [Abstract][Full Text] [Related]
78. The role of peroxiredoxin I in cisplatin-induced ototoxicity.
Le Q; Tabuchi K; Warabi E; Hara A
Auris Nasus Larynx; 2017 Apr; 44(2):205-212. PubMed ID: 27318370
[TBL] [Abstract][Full Text] [Related]
79. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
80. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.
Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B
FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
